QA: Aravive Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2019_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 58,030,000
1 IntangibleAssetsNetIncludingGoodwill 341,000
2 PropertyPlantAndEquipmentNet 32,000
3 remainder_Assets 11,067,000
4 LiabilitiesCurrent 1,937,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,588,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,387,517
9 ResearchAndDevelopmentExpense 38,784,662
10 remainder_Expenses -239,067
11 remainder_Revenues 36,289,579
12 remainder_NetIncome 744,088
13 remainder_ComprehensiveNetIncome 206,528
  yvar yval
0 Assets 69,470,000
1 Liabilities 9,525,000
2 Expenses 63,933,112
3 Revenues 36,289,579
4 StockholdersEquity 59,945,000
5 NetIncome -26,899,445
6 ComprehensiveNetIncome -26,796,181
7 BaseVar 90,084,154
8 EconomicCapitalRatiobeforeLimitedLiability 2.63
9 EconomicCapitalRatio 3.44

Edgar->Model Mapping

Feature Distribution

Change over Time